Court Madera, CA, United States of America

David Braun Kanne


Average Co-Inventor Count = 4.5

ph-index = 6

Forward Citations = 161(Granted Patents)


Location History:

  • Corte Madera, CA (US) (2012 - 2021)
  • Court Madera, CA (US) (2021)

Company Filing History:


Years Active: 2012-2021

Loading Chart...
12 patents (USPTO):Explore Patents

Title: David Braun Kanne: Innovator in Immune Therapeutics

Introduction

David Braun Kanne, based in Corte Madera, California, is an influential inventor known for his significant contributions to the field of immune therapeutics. With a remarkable portfolio of 12 patents, Kanne has been at the forefront of developing innovative solutions that leverage immune stimulation for therapeutic applications.

Latest Patents

Among his notable inventions are two recent patents focusing on locked nucleic acid cyclic dinucleotide compounds. The first patent introduces highly active locked nucleic acid cyclic-dinucleotide immune stimulators designed to activate dendritic cells (DCs) through the cytoplasmic receptor known as STING (Stimulator of Interferon Genes). This groundbreaking invention provides a composition comprising one or more cyclic dinucleotides that induce human STING-dependent type I interferon production, highlighting the potential for enhanced immune responses.

The second patent encompasses novel compositions and methods for activating STING-dependent signaling. This invention presents highly active cyclic-di-nucleotide immune stimulators that likewise activate DCs via STING. The compositions featured in this patent include 2'-fluoro substituted, bis-3',5' cyclin purine dinucleotides, revealing another dimension of Kanne's innovative approach to immune modulation.

Career Highlights

Kanne has worked with several prominent companies, including Aduro Biotech Inc. and Chinook Therapeutics, Inc. His career reflects a steadfast commitment to advancing immune therapeutics, blending his scientific expertise with practical applications that have the potential to transform clinical practices.

Collaborations

Throughout his career, David Braun Kanne has collaborated with notable professionals, including Thomas W. Dubensky, Jr. and Laura Hix Glickman. These collaborations have fostered an environment of innovation, contributing significantly to the development and commercialization of his patented technologies.

Conclusion

David Braun Kanne stands out as a dedicated inventor whose contributions are paving the way for new therapeutic strategies in immunology. His unwavering commitment to innovation and his extensive patent portfolio position him as a key figure in the ongoing quest for advancements in immune therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…